These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 26923897)

  • 41. A budget impact model for biosimilar infliximab in Crohn's disease in Bulgaria, the Czech Republic, Hungary, Poland, Romania, and Slovakia.
    Brodszky V; Rencz F; Péntek M; Baji P; Lakatos PL; Gulácsi L
    Expert Rev Pharmacoecon Outcomes Res; 2016; 16(1):119-25. PubMed ID: 26162458
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Infliximab therapy in a patient with refractory ileocolic Crohn's disease and Takayasu arteritis.
    Calderón R; Estrada S; Ramírez de la Piscina P; Salvador M; Zabaleta S; Enciso C; Delgado E; García-Campos F
    Rev Esp Enferm Dig; 2010 Feb; 102(2):145-6. PubMed ID: 20361852
    [No Abstract]   [Full Text] [Related]  

  • 43. Anti-TNF therapy is associated with a reduction in radiation exposure in patients with Crohn's disease.
    Aggarwal D; Limdi JK
    Eur J Gastroenterol Hepatol; 2015 Jan; 27(1):13-9. PubMed ID: 25341058
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Long-term partial remission of autoimmune thrombocytopenia in a patient treated with the anti-tumor necrosis factor-alpha antibody infliximab for refractory fistulizing Crohn's disease.
    de Rossi TM; Krauss N; Voll RE; Nägel A; Weidenhiller M; Konturek PC; Hahn EG; Raithel M
    Digestion; 2008; 78(4):195-200. PubMed ID: 19122456
    [TBL] [Abstract][Full Text] [Related]  

  • 45. A Rare Cause of Painful Skin Rash in Crohn's Disease.
    Umapathy C; Seth N; Ganesh S
    Gastroenterology; 2017 Jan; 152(1):29-30. PubMed ID: 27889378
    [No Abstract]   [Full Text] [Related]  

  • 46. Management of Crohn's disease--a practical approach.
    Knutson D; Greenberg G; Cronau H
    Am Fam Physician; 2003 Aug; 68(4):707-14. PubMed ID: 12952387
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Familial Mediterranean fever. Case of a 48-year-old patient with recurrent abdominal pain].
    Hofer JF; Franz B; Holzinger G
    Wien Klin Wochenschr; 1992; 104(7):208-10. PubMed ID: 1381854
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Sacroiliitis in familial Mediterranean fever: an unusual presentation in childhood.
    Beşbaş N; Ozdemir S; Saatçi I; Bakkaloğlu A; Ozen S; Saatçi U
    Turk J Pediatr; 1999; 41(3):387-90. PubMed ID: 10770103
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The association of infliximab trough levels with disease activity in pediatric inflammatory bowel disease.
    Hoekman DR; Brandse JF; de Meij TG; Hummel TZ; Löwenberg M; Benninga MA; D'Haens GR; Kindermann A
    Scand J Gastroenterol; 2015; 50(9):1110-7. PubMed ID: 25865965
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Atypical Henoch-Schonlein purpura: a forerunner of familial Mediterranean fever.
    Adiv OE; Butbul Y; Nutenko I; Brik R
    Isr Med Assoc J; 2011 Apr; 13(4):209-11. PubMed ID: 21598807
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Indications and results of infliximab in Crohn's disease].
    Karoui S; Boubaker J; Filali A
    Tunis Med; 2004 Dec; 82(12):1057-63. PubMed ID: 15822505
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Refractory Crohn's disease of the vulva treated with infliximab: a case report.
    Makhija S; Trotter M; Wagner E; Coderre S; Panaccione R
    Can J Gastroenterol; 2007 Dec; 21(12):835-7. PubMed ID: 18080056
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Long-term outcome of perianal fistulizing Crohn's disease treated with infliximab.
    Bouguen G; Siproudhis L; Gizard E; Wallenhorst T; Billioud V; Bretagne JF; Bigard MA; Peyrin-Biroulet L
    Clin Gastroenterol Hepatol; 2013 Aug; 11(8):975-81.e1-4. PubMed ID: 23376316
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [A case of Takayasu's arteritis detected in a patient with Crohn's disease following infliximab treatment].
    Miyakawa M; Tanaka H; Yamashita M; Sakemi R; Nasuno M; Ishii M; Yanagisawa H; Ichihara S; Gotoda H; Motoya S
    Nihon Shokakibyo Gakkai Zasshi; 2016; 113(10):1761-1768. PubMed ID: 27725465
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [A urachus cyst revealing a torpid Crohn's disease in a young adult with chronic fever].
    Weitten T; Coca C; Ben Abdelghani M; Rohr S; Boujan E; Blicklé JF; Andrès E
    Presse Med; 2005 Apr; 34(8):581-2. PubMed ID: 15962496
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Incidence of familial Mediterranean fever (FMF) mutations among children of Mediterranean extraction with functional abdominal pain.
    Brik R; Litmanovich D; Berkowitz D; Shamir R; Rosenthal E; Shinawi M; Gershoni-Baruch R
    J Pediatr; 2001 May; 138(5):759-62. PubMed ID: 11343058
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The impact of infliximab induction therapy on mucosal healing and clinical remission in Polish pediatric patients with moderate-to-severe Crohn's disease.
    Kierkus J; Dadalski M; Szymanska E; Oracz G; Wegner A; Gorczewska M; Szymanska S; Woynarowski M; Ryzko J
    Eur J Gastroenterol Hepatol; 2012 May; 24(5):495-500. PubMed ID: 22387887
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Adalimumab treatment in infliximab-resistant pediatric patient with Crohn's disease].
    Veres G; Putz R; Szabó D; Molnár K; Bodánszky H; Dezsofi A; Arató A
    Orv Hetil; 2009 Oct; 150(40):1858-60. PubMed ID: 19789146
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Infliximab treatment for symptomatic Crohn's disease strictures.
    Pelletier AL; Kalisazan B; Wienckiewicz J; Bouarioua N; Soulé JC
    Aliment Pharmacol Ther; 2009 Feb; 29(3):279-85. PubMed ID: 19035967
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Extensive abdominal aortitis in a patient with Crohn's disease.
    Lebude B; Orloff M; Coben R
    J Cardiovasc Med (Hagerstown); 2012 Sep; 13(9):587-9. PubMed ID: 22499004
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.